# Testosterone Regulation of the Natriuretic Peptide System

> **NCT02269072** · NA · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Testosterone
- **DRUG:** Nesiritide
- **DRUG:** Leuprolide
- **DRUG:** Anastrozole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02269072
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02269072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02269072, "Testosterone Regulation of the Natriuretic Peptide System". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02269072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*